Literature DB >> 31264179

Late relapse of primary hemophagocytic lymphohistiocytosis after hematopoietic stem cell transplantation: a consequence of low-level chimerism from a carrier donor?

Amy E Verrinder1, Joanna L S Marsden1, Mary A Slatter1,2, Leigh McDonald3, Chris M Bacon4,5, Joaquim Majo4, Andrew R Gennery6,7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31264179     DOI： 10.1007/s12026-019-09085-9

Source DB:  PubMed          Journal:  Immunol Res        ISSN： 0257-277X            Impact factor:   2.829


× No keyword cloud information.
  9 in total

Review 1.  Hemophagocytic lymphohistiocytosis: pathogenesis and treatment.

Authors:  Gritta E Janka; Kai Lehmberg
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2013

2.  Reduced-intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation.

Authors:  Rebecca A Marsh; Gretchen Vaughn; Mi-Ok Kim; Dandan Li; Sonata Jodele; Sarita Joshi; Parinda A Mehta; Stella M Davies; Michael B Jordan; Jack J Bleesing; Alexandra H Filipovich
Journal:  Blood       Date:  2010-09-20       Impact factor: 22.113

3.  Heterozygosity for the common perforin mutation, p.A91V, impairs the cytotoxicity of primary natural killer cells from healthy individuals.

Authors:  Imran G House; Kevin Thia; Amelia J Brennan; Richard Tothill; Alexander Dobrovic; Wei Z Yeh; Richard Saffery; Zac Chatterton; Joseph A Trapani; Ilia Voskoboinik
Journal:  Immunol Cell Biol       Date:  2015-03-17       Impact factor: 5.126

4.  Calcium-dependent plasma membrane binding and cell lysis by perforin are mediated through its C2 domain: A critical role for aspartate residues 429, 435, 483, and 485 but not 491.

Authors:  Ilia Voskoboinik; Marie-Claude Thia; Jamie Fletcher; Annette Ciccone; Kylie Browne; Mark J Smyth; Joseph A Trapani
Journal:  J Biol Chem       Date:  2004-12-02       Impact factor: 5.157

5.  Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis.

Authors:  Sebastiaan J Vastert; Richard van Wijk; Leila E D'Urbano; Karen M K de Vooght; Wilco de Jager; Angelo Ravelli; Silvia Magni-Manzoni; Antonella Insalaco; Elisabetta Cortis; Wouter W van Solinge; Berent J Prakken; Nico M Wulffraat; Fabrizio de Benedetti; Wietse Kuis
Journal:  Rheumatology (Oxford)       Date:  2009-12-17       Impact factor: 7.580

6.  Fatal hemophagocytic lymphohistiocytosis in X-linked chronic granulomatous disease associated with a perforin gene variant.

Authors:  Joris M van Montfrans; Eva Rudd; Lisette van de Corput; Jan-Inge Henter; Peter Nikkels; Nico Wulffraat; Jaap J Boelens
Journal:  Pediatr Blood Cancer       Date:  2009-04       Impact factor: 3.167

7.  The minimum required level of donor chimerism in hereditary hemophagocytic lymphohistiocytosis.

Authors:  Bernd Hartz; Rebecca Marsh; Kanchan Rao; Jan-Inge Henter; Michael Jordan; Lisa Filipovich; Peter Bader; Rita Beier; Birgit Burkhardt; Roland Meisel; Ansgar Schulz; Beate Winkler; Michael H Albert; Johann Greil; Gülsün Karasu; Wilhelm Woessmann; Selim Corbacioglu; Bernd Gruhn; Wolfgang Holter; Jörn-Sven Kühl; Peter Lang; Markus G Seidel; Paul Veys; Alexandra Löfstedt; Sandra Ammann; Stephan Ehl; Gritta Janka; Ingo Müller; Kai Lehmberg
Journal:  Blood       Date:  2016-04-20       Impact factor: 22.113

8.  Hematopoietic stem cell transplantation in hemophagocytic lymphohistiocytosis: a single-center report of 48 patients.

Authors:  Marie Ouachée-Chardin; Caroline Elie; Geneviève de Saint Basile; Françoise Le Deist; Nizar Mahlaoui; Capucine Picard; Bénédicte Neven; Jean-Laurent Casanova; Marc Tardieu; Marina Cavazzana-Calvo; Stéphane Blanche; Alain Fischer
Journal:  Pediatrics       Date:  2006-03-20       Impact factor: 7.124

9.  T-cell gene therapy for perforin deficiency corrects cytotoxicity defects and prevents hemophagocytic lymphohistiocytosis manifestations.

Authors:  Sujal Ghosh; Marlene Carmo; Miguel Calero-Garcia; Ida Ricciardelli; Juan Carlos Bustamante Ogando; Michael P Blundell; Axel Schambach; Philip G Ashton-Rickardt; Claire Booth; Stephan Ehl; Kai Lehmberg; Adrian J Thrasher; H Bobby Gaspar
Journal:  J Allergy Clin Immunol       Date:  2018-01-31       Impact factor: 10.793
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.